CD22-directed Immunoconjugate drugs
1 medication in the FDA established pharmacologic class “CD22-directed Immunoconjugate”.
| Drug | Type | NDC products |
|---|---|---|
| Besponsa inotuzumab ozogamicin | Rx | 1 |
1 medication in the FDA established pharmacologic class “CD22-directed Immunoconjugate”.
| Drug | Type | NDC products |
|---|---|---|
| Besponsa inotuzumab ozogamicin | Rx | 1 |